The global anti-aging market size was USD 68.35 billion in 2023, calculated at USD 73 billion in 2024 and is expected to reach around USD 140.94 billion by 2034, expanding at a CAGR of 6.8% from 2024 to 2034.
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Anti-aging Market
5.1. COVID-19 Landscape: Anti-aging Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Anti-aging Market, By Products Type
8.1. Anti-aging Market, by Products Type, 2024-2034
8.1.1. Anti-wrinkle
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Hair color
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Ultraviolet absorption
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Anti-stretch mark
8.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 9. Global Anti-aging Market, By Treatment Type
9.1. Anti-aging Market, by Treatment Type, 2024-2034
9.1.1. Hair restoration
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Anti-pigmentation
9.1.2.1. Market Revenue and Forecast (2021-2034)
9.1.3. Adult acne therapy
9.1.3.1. Market Revenue and Forecast (2021-2034)
9.1.4. Breast augmentation
9.1.4.1. Market Revenue and Forecast (2021-2034)
9.1.5. Liposuction
9.1.5.1. Market Revenue and Forecast (2021-2034)
9.1.6. Chemical Peel
9.1.6.1. Market Revenue and Forecast (2021-2034)
Chapter 10. Global Anti-aging Market, By Demography Type
10.1. Anti-aging Market, by Demography Type, 2024-2034
10.1.1. Generation X
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. Baby Boomers
10.1.2.1. Market Revenue and Forecast (2021-2034)
10.1.3. Generation Y
10.1.3.1. Market Revenue and Forecast (2021-2034)
10.1.4. Generation Z
10.1.4.1. Market Revenue and Forecast (2021-2034)
Chapter 11. Global Anti-aging Market, By Devices Type
11.1. Anti-aging Market, by Devices Type, 2024-2034
11.1.1. Anti-cellulite treatment
11.1.1.1. Market Revenue and Forecast (2021-2034)
11.1.2. Laser aesthetic devices
11.1.2.1. Market Revenue and Forecast (2021-2034)
11.1.3. Microdermabrasion devices
11.1.3.1. Market Revenue and Forecast (2021-2034)
11.1.4. Radio frequency devices
11.1.4.1. Market Revenue and Forecast (2021-2034)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2021-2034)
Chapter 12. Global Anti-aging Market, By End User Type
12.1. Anti-aging Market, by End User, 2024-2034
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2021-2034)
12.1.2. Clinics
12.1.2.1. Market Revenue and Forecast (2021-2034)
12.1.3. Home healthcare
12.1.3.1. Market Revenue and Forecast (2021-2034)
Chapter 13. Global Anti-aging Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Products (2021-2034)
13.1.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.1.3. Market Revenue and Forecast, by Demography (2021-2034)
13.1.4. Market Revenue and Forecast, by Devices (2021-2034)
13.1.5. Market Revenue and Forecast, by End User (2021-2034)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Products (2021-2034)
13.1.6.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.1.6.3. Market Revenue and Forecast, by Demography (2021-2034)
13.1.6.4. Market Revenue and Forecast, by Devices (2021-2034)
13.1.7. Market Revenue and Forecast, by End User (2021-2034)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Products (2021-2034)
13.1.8.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.1.8.3. Market Revenue and Forecast, by Demography (2021-2034)
13.1.8.4. Market Revenue and Forecast, by Devices (2021-2034)
13.1.8.5. Market Revenue and Forecast, by End User (2021-2034)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Products (2021-2034)
13.2.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.2.3. Market Revenue and Forecast, by Demography (2021-2034)
13.2.4. Market Revenue and Forecast, by Devices (2021-2034)
13.2.5. Market Revenue and Forecast, by End User (2021-2034)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Products (2021-2034)
13.2.6.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.2.6.3. Market Revenue and Forecast, by Demography (2021-2034)
13.2.7. Market Revenue and Forecast, by Devices (2021-2034)
13.2.8. Market Revenue and Forecast, by End User (2021-2034)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Products (2021-2034)
13.2.9.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.2.9.3. Market Revenue and Forecast, by Demography (2021-2034)
13.2.10. Market Revenue and Forecast, by Devices (2021-2034)
13.2.11. Market Revenue and Forecast, by End User (2021-2034)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Products (2021-2034)
13.2.12.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.2.12.3. Market Revenue and Forecast, by Demography (2021-2034)
13.2.12.4. Market Revenue and Forecast, by Devices (2021-2034)
13.2.13. Market Revenue and Forecast, by End User (2021-2034)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Products (2021-2034)
13.2.14.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.2.14.3. Market Revenue and Forecast, by Demography (2021-2034)
13.2.14.4. Market Revenue and Forecast, by Devices (2021-2034)
13.2.15. Market Revenue and Forecast, by End User (2021-2034)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Products (2021-2034)
13.3.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.3.3. Market Revenue and Forecast, by Demography (2021-2034)
13.3.4. Market Revenue and Forecast, by Devices (2021-2034)
13.3.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Products (2021-2034)
13.3.6.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.3.6.3. Market Revenue and Forecast, by Demography (2021-2034)
13.3.6.4. Market Revenue and Forecast, by Devices (2021-2034)
13.3.7. Market Revenue and Forecast, by End User (2021-2034)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Products (2021-2034)
13.3.8.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.3.8.3. Market Revenue and Forecast, by Demography (2021-2034)
13.3.8.4. Market Revenue and Forecast, by Devices (2021-2034)
13.3.9. Market Revenue and Forecast, by End User (2021-2034)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Products (2021-2034)
13.3.10.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.3.10.3. Market Revenue and Forecast, by Demography (2021-2034)
13.3.10.4. Market Revenue and Forecast, by Devices (2021-2034)
13.3.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Products (2021-2034)
13.3.11.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.3.11.3. Market Revenue and Forecast, by Demography (2021-2034)
13.3.11.4. Market Revenue and Forecast, by Devices (2021-2034)
13.3.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Products (2021-2034)
13.4.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.4.3. Market Revenue and Forecast, by Demography (2021-2034)
13.4.4. Market Revenue and Forecast, by Devices (2021-2034)
13.4.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Products (2021-2034)
13.4.6.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.4.6.3. Market Revenue and Forecast, by Demography (2021-2034)
13.4.6.4. Market Revenue and Forecast, by Devices (2021-2034)
13.4.7. Market Revenue and Forecast, by End User (2021-2034)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Products (2021-2034)
13.4.8.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.4.8.3. Market Revenue and Forecast, by Demography (2021-2034)
13.4.8.4. Market Revenue and Forecast, by Devices (2021-2034)
13.4.9. Market Revenue and Forecast, by End User (2021-2034)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Products (2021-2034)
13.4.10.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.4.10.3. Market Revenue and Forecast, by Demography (2021-2034)
13.4.10.4. Market Revenue and Forecast, by Devices (2021-2034)
13.4.10.5. Market Revenue and Forecast, by End User (2021-2034)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Products (2021-2034)
13.4.11.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.4.11.3. Market Revenue and Forecast, by Demography (2021-2034)
13.4.11.4. Market Revenue and Forecast, by Devices (2021-2034)
13.4.11.5. Market Revenue and Forecast, by End User (2021-2034)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Products (2021-2034)
13.5.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.5.3. Market Revenue and Forecast, by Demography (2021-2034)
13.5.4. Market Revenue and Forecast, by Devices (2021-2034)
13.5.5. Market Revenue and Forecast, by End User (2021-2034)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Products (2021-2034)
13.5.6.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.5.6.3. Market Revenue and Forecast, by Demography (2021-2034)
13.5.6.4. Market Revenue and Forecast, by Devices (2021-2034)
13.5.7. Market Revenue and Forecast, by End User (2021-2034)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Products (2021-2034)
13.5.8.2. Market Revenue and Forecast, by Treatment (2021-2034)
13.5.8.3. Market Revenue and Forecast, by Demography (2021-2034)
13.5.8.4. Market Revenue and Forecast, by Devices (2021-2034)
13.5.8.5. Market Revenue and Forecast, by End User (2021-2034)
Chapter 14. Company Profiles
14.1. Unilever Group
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. GALDERMA LABORATORIES L.P.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Procter & Gamble (P&G) Company
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Nu Skin Enterprises Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Hologic Inc.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Pierre Fabre S.A.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Shiseido Company Limited
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Candela Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Home Skinovations Ltd.
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Estee Lauder
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client